Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-20-000738
Filing Date
2020-09-30
Accepted
2020-09-30 13:52:00
Documents
1
Period of Report
2020-09-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4005
  Complete submission text file 0001192482-20-000738.txt   5565
Mailing Address C/O ORCHARD THERAPEUTICS 101 SEAPORT BOULEVARD, 7TH FLOOR BOSTON MA 02210
Business Address
THOMAS FRANK E (Reporting) CIK: 0001242616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36510 | Film No.: 201211805

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Issuer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations